Services
Research & Clinical Development Solutions
Product Development
Regulatory
Clinical
Biometrics
CMC
Technology-Powered Consulting
Management Consulting
Market Access
Patient Engagement
Transaction Advisory
Advanced Analytics
Real-World Evidence
Real-World Evidence
Technology
Health Storylines
A digital platform that puts patients at the center and intersection of human networks, technology, and science
b.research
A single, unified SaaS solution for all EU Phase 4, Real-World Evidence, and Post-Approval studies
b.therapeutics
A platform of do-it-yourself services around the patient, for tracking therapeutic and patient progress
MyReco
A dynamic and empathetic virtual assistant to keep patients motivated so that compliance, retention, and efficiency of trial timelines are maximized
About
Our team
Our team collaborates to fully understand every aspect of each client’s organization from concept ideation to commercial realization, from innovation to implementation
Community involvement
We work with our local and global communities to create positive change through education, service, and sustainable business practices
600+
employees
90+%
has a PhD and/or Masters
15
languages spoken
30
nationalities
Careers
Job openings
Explore our job openings and find the one that is right for you
Why work at Alira Health?
Alira Health is dedicated to providing market-leading professional development, education, travel, and work-life benefits to all team members
Join our team
Join our global team dedicated to innovation and initiative, where physical walls and different time zones don’t limit, but encourage, collaboration
Resources
News
Read all the latest from us
Events
Check out our upcoming events
Publications
Discover our latest industry infographics, articles, white papers, and more
Multimedia
View our videos, podcasts, webinars, and more
Latest in the hub
Alira Health and Biocat Startup Support Program Presentation
Published: January, 2023
Alligator-Derived Hyaluronic Acid: Bacteriostatic and Fungastatic Properties Against Pathogens
Published: January, 2023
Myasthenia Gravis Foundation of America (MGFA) Re-launches the MGFA Global MG Patient Registry with Partner Alira Health
Published: January, 2023
Services
Overview
Research & Clinical Development Solutions
Product Development Regulatory Clinical Biometrics CMC
Technology-Powered Consulting
Management Consulting Market Access Patient Engagement Transaction Advisory Advanced Analytics
Real-World Evidence
Real-World Evidence
Technology
Overview Health Storylines b.research b.therapeutics MyReco
About
Overview Our team Community involvement
Careers
Overview Job openings Why work at Alira Health? Join our team
Resources
Overview News Events Publications Multimedia
Home > Education Hub > WHO Guideline: Summary of Recommendations on Pharmaceutical Pricing Policies

WHO Guideline: Summary of Recommendations on Pharmaceutical Pricing Policies

How will the new WHO recommendations on pharmaceutical pricing policies affect your organization?

Multimedia
Category:
Market Access Pharma
Published on:
November 2, 2020

The WHO recently launched a series of recommendations on pharmaceutical pricing policies to help countries make medicines more affordable for the global population and lessen the burden on government budgets.

Alira Health’s Nerea Blanque-Catalina, VP, Market Access & Pricing, and Luis Culla, Associate Director, Global Market Access, dive into these new recommendations and provide advice on how companies can manage the impact of these new guidelines.

LISTEN TO THE EPISODE BELOW

For more information and to connect with the team, contact us here.

Related news

Events January 27, 2023
Alira Health and Biocat Startup Support Program Presentation
Biocat and Alira Health partnered to foster Market Access for startups. Alira Health, a global healthcare advisory and technology company, and Biocat, a strategic stakeholder building(...)
Market Access Startups
Publications January 20, 2023
Insights on Market Access
To get her perspective on market access and what to expect in 2023, we spoke with Nerea Blanqué, Senior Vice President of Market Access and Pricing at Alira Health.
Market Access Medical Devices Pharma
Publications January 18, 2023
The State of Biopharma Funding
We spoke with Joris Pezzini, Executive Vice President of Biopharma, Alira Health, during the J.P. Morgan Healthcare Conference in San Francisco, which brings together investors and(...)
Biopharma Biotech Funding Pharma
Publications December 21, 2022
2022 Recap: Your Favorite Alira Health Publications
In 2022, the Alira Health team of scientists, strategists, economists, clinicians, and biostatisticians shared actionable insights, industry thought leadership, and leading-edge guidance(...)
Clinical Digital Health Market Access MedTech Pharma Regulatory
News November 15, 2022
Alira Health Partners with Policy Matters to Foster Market Access in the UK
Alira Health, a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, announces its partnership with leading UK market access specialist(...)
Digital Health Healthcare Consulting Market Access
News November 10, 2022
Alira Health and GDMH together to boost Life Sciences innovation
The companies join forces for collaborative research and co-development of projects in the fields of Digital Health, Real-World Evidence and Market Access.
Clinical Trials Digital Health DTx Market Access Real-World Evidence RWE
Publications November 8, 2022
Debate sobre los IPT en oncología: buscando puntos de mejora en la evaluación y acceso de los fármacos oncológicos en España
For our Spanish community members, we are glad to share the Debate on IPT in oncology: Looking for points of improvement in the evaluation and access of oncological drugs in Spain.
Oncology Pharma Spain
See all news
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.